Krishnaprasad Subbarao
In order to view Krishnaprasad Subbarao's profile, please login
Login
ABOUT

You must be logged in to see Krishnaprasad Subbarao's about summary.

I have a PhD. degree from The Weizmann Institute of Science, Israel, followed by Postdoctoral studies at The Brown Cancer Centre, University Of Louisville, Kentucky, US.
I was instrumental in starting oncology program at Aurigene for the first time along with Chief Scientific Officer and Cell Biology scientists and I have 8 years of experience working at Aurigene Discovery Technologies (a wholly owned subsidiary of Dr. Reddy’s lab) heading the Pharmacology lab especially oncology Pharmacology, supporting both collaborative projects with Pharma giants as well as in-house oncology drug discovery programs. Some of the targets that we worked on are MEK inhibitors (with Novartis), EGFR inhibitors (with Sanofi), BRaf inhibitors (with Endo Pharma), PIM kinase inhibitors (with Abbott), CYP17 inhibitors (again with Novartis), PD1, PDL1 peptide inhibitors (in-house program), DHODH inhibitors (in-house program) and Matriptase inhibitors (with Orion Pharma).

Contact & Other Info

You must be logged in to see Krishnaprasad Subbarao's contact details.

Education

You must be logged in to see Krishnaprasad Subbarao's education details.

Experience

You must be logged in to see Krishnaprasad Subbarao's work experience details.